Observational Studies on Evaluating the Safety and Adverse Effects of Traditional Chinese Medicine

被引:25
|
作者
Lai, Jung-Nein [1 ,2 ]
Tang, Jin-Ling [3 ,4 ]
Wang, Jung-Der [5 ]
机构
[1] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan
[2] Taipei City Hosp, Dept Chinese Med, Yangming Branch, Taipei 111, Taiwan
[3] Peking Univ, Hlth Sci Ctr, Ctr Evidence Based Med, Beijing 100871, Peoples R China
[4] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China
[5] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 701, Taiwan
关键词
ALTERNATIVE MEDICINE; KIDNEY-DISEASE; ARISTOLOCHIC ACIDS; HERBAL PRODUCTS; COMPLEMENTARY; RISK;
D O I
10.1155/2013/697893
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background. This study aims to share our experiences when carrying out observational studies of traditional Chinese medicine (TCM). Methods. We have proactively monitored the safety profiles of Duhuo Jisheng Tang (DJT), Suan Zao Ren Tang (SZRT), and TMN-1. A list of adverse events (AEs), complete blood counts, and liver and kidney function tests were obtained from the participants during their scheduled hospital visits. Retrospective observational studies were conducted based on the reimbursement database of the National Health Insurance system, Taiwan, to explore the relationship between the use of TCM that have been adulterated by aristolochic acid and the risk from both nephrotoxins and carcinogens. Results. A total of 221, 287, and 203 AEs were detected after SZRT, DJT, and TMN-1 had been taken, respectively. Dizziness, headache, stomach ache, and diarrhea were judged to be probably related to SZRT treatment. Retrospective observational studies found an association between the consumption of aristolochic acid-containing Chinese formulae such as Mu Tong and an increased risk of CKD, ESRD, and urinary tract cancer. Conclusion. Prospective and retrospective observational studies seem to have specific advantages when investigating the safety and adverse effects of TCM therapies, as well as possibly other alternative/complementary therapies.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] THE INHIBITION EFFECTS OF A TRADITIONAL CHINESE MEDICINE ON GLIOBLASTOMA
    Huang, H.
    Yue, G.
    Qu, Y.
    Wang, Q.
    Li, N.
    Li, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 317 - 317
  • [32] The Regulatory Effects of Traditional Chinese Medicine on Ferroptosis
    Gao, Qian
    Yin, Xue-dong
    Zhang, Fan
    Zhu, Yi-Zhun
    Li, Zhi-ling
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [33] Separation and pharmacological effects of traditional Chinese medicine
    Wu, Xiong-Zhi
    TRADITIONAL MEDICINE RESEARCH, 2018, 3 (03):
  • [34] Bidirectional effects and mechanisms of traditional Chinese medicine
    Peng, Xiaonian
    Tang, Fang
    Yang, Yong
    Li, Tiandan
    Hu, Xiaochao
    Li, Sha
    Wu, Weihua
    He, Kai
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 298
  • [35] Investigating adverse effects of Chinese herbal medicine
    Shaw, D
    DRUG SAFETY, 2005, 28 (10) : 939 - 940
  • [36] Contact dermatitis: a common adverse reaction to topical traditional Chinese medicine
    Sen, Priya
    Ho, Madeline S. L.
    Ng, See-Ket
    Yosipovitch, Gil
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (11) : 1255 - 1260
  • [37] Application of Microdialysis for Pharmacokinetics of Traditional Chinese Medicine Studies
    Cao, Gang
    Cai, Hao
    Cong, Xiaodong
    Zhang, Yun
    Shao, Yulan
    Cai, Baochang
    ANALYTICAL LETTERS, 2010, 43 (01) : 55 - 72
  • [38] Challenges and Solutions of Pharmacokinetics for Efficacy and Safety of Traditional Chinese Medicine
    Li, Yazhuo
    Wang, Yanli
    Tai, Wen
    Yang, Ling
    Chen, Yong
    Chen, Changqing
    Liu, Changxiao
    CURRENT DRUG METABOLISM, 2015, 16 (09) : 765 - 776
  • [39] Safety Research in Traditional Chinese Medicine: Methods, Applications, and Outlook
    Gao, Yue
    Liang, Aihua
    Fan, Xiaohui
    Hu, Limin
    Hao, Feiran
    Li, Yubo
    ENGINEERING, 2019, 5 (01) : 76 - 82
  • [40] Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome
    Wu, Haoran
    Tian, Jiaxing
    Dai, Dan
    Liao, Jiangquan
    Wang, Xinmiao
    Wei, Xiuxiu
    Jin, De
    An, Xuedong
    Lian, Fengmei
    Tong, Xiaolin
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)